feed,title,long_url,short_url
Benzinga,Forma Therapeutics Stock Drops After Disappointing EHA Presentation For Etavopivat In Sickle Cell Disease,https://benzinga.com/general/biotech/21/06/21530997/forma-therapeutics-stock-drops-after-disappointing-eha-presentation-for-etavopivat-in-sickle-cell,https://j.mp/3cCthNn
